Showing results (41-50 of 74) with videos related to

Sort By:
Pageof 8
Oncogene|September 5, 2003
High tumorigenic potential of a constitutively active mutant of the cholecystokinin 2 receptorCéline Galés, Didier Sanchez, Marc Poirot, et al.
The Journal of Steroid Biochemistry and Molecular Biology|September 8, 2023
Chemical synthesis and biochemical properties of cholestane-5α,6β-diol-3-sulfonate: A non-hydrolysable analogue of cholestane-5α,6β-diol-3β-sulfatePhilippe de Médina, Silia Ayadi, Régis Soulès, et al.
Chemistry and Physics of Lipids|May 31, 2017
Improvement of 5,6α-epoxycholesterol, 5,6β-epoxycholesterol, cholestane-3β,5α,6β-triol and 6-oxo-cholestan-3β,5α-diol recovery for quantification by GC/MSRegis Soules, Emmanuel Noguer, Luigi Iuliano, et al.
The Journal of Biological Chemistry|June 4, 2004
Molecular characterization of the microsomal tamoxifen binding siteBlandine Kedjouar, Philippe de Médina, Mustapha Oulad-Abdelghani, et al.
Molecular Pharmacology|April 16, 2003
Identification of tyrosine 189 and asparagine 358 of the cholecystokinin 2 receptor in direct interaction with the crucial C-terminal amide of cholecystokinin by molecular modeling, site-directed mutagenesis, and structure/affinity studiesCéline Galés, Marc Poirot, Julien Taillefer, et al.
Bioorganic & Medicinal Chemistry|June 15, 2010
Development of a new radioligand for cholecystokinin receptor subtype 2 scintigraphy: from molecular modeling to in vivo evaluationSéverine Brillouet, Sandra Dorbes, Frédéric Courbon, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 18, 2003
Tamoxifen is a potent inhibitor of cholesterol esterification and prevents the formation of foam cellsPhilippe de Medina, Bruno L Payré, José Bernad, et al.
Chemistry and Physics of Lipids|June 7, 2011
Importance of cholesterol and oxysterols metabolism in the pharmacology of tamoxifen and other AEBS ligandsPhilippe de Medina, Michael R Paillasse, Gregory Ségala, et al.
The Journal of Biological Chemistry|November 29, 2001
The biologically crucial C terminus of cholecystokinin and the non-peptide agonist SR-146,131 share a common binding site in the human CCK1 receptor. Evidence for a crucial role of Met-121 in the activation processChantal Escrieut, Véronique Gigoux, Elodie Archer, et al.
Molecules (Basel, Switzerland)|February 2, 2019
HPLC Analysis and Skin Whitening Effects of Umbelliprenin-containing Extracts of Anethum Graveolens, Pimpinella Anisum, and Ferulago CampestrisVito Alessandro Taddeo, Francesco Epifano, Francesca Preziuso, et al.
Pageof 8